Dachaigh › Gnìomhan › Medical Scientists, Except Epidemiologists › Waltham, MA
Medical Scientists, Except Epidemiologists ann an Waltham, MA: Tuarastalan H-1B
60 iarrtasan cumhaichean-obrach airson an dreuchd seo le làrach-obrach ann an Waltham, MA. Tuarastal bunasach meadhanach $125,330; leth meadhanach $109,024–$147,675.
A rèir ìre tuarastail
| Ìre tuarastail | Tuarastal meadhanach |
|---|---|
| Ìre I (innte) | $115,000 |
| Ìre II (càileachail) | $116,002 |
| Ìre III (eòlach) | $133,000 |
| Ìre IV (gu lèir comasach) | $164,116 |
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Luchd-fastaidh
| Neach-obrach | LCAs | Tuarastal meadhanach |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $159,125 |
| Sanofi Pasteur Inc. | 9 | $100,500 |
| Seqirus Inc. | 9 | $120,000 |
| GlaxoSmithKline LLC | 6 | $144,898 |
| Sanofi US Services Inc. | 4 | $108,284 |
| Bioverativ Therapeutics, Inc. | 2 | $124,051 |
| Xilio Development Inc. | 2 | $122,000 |
| Apellis Pharmaceuticals Inc. | 2 | $155,732 |
| Trinity Partners, LLC | 2 | $147,500 |
| Sanofi Vaccines US Inc. | 2 | $114,657 |
| Orionis Biosciences Inc. | 1 | $180,000 |
| Sarepta Therapeutics, Inc. | 1 | $150,000 |
| AMAG Pharmaceuticals, Inc. | 1 | $164,116 |
| RVAC Medicines (US), Inc. | 1 | $110,000 |
| Photys Therapeutics Inc. | 1 | $88,962 |
| Certara USA Inc. | 1 | $120,000 |
| Children's Hospital Corporation | 1 | $73,000 |
| Visterra, Inc. | 1 | $285,000 |
| Viridian Therapeutics, Inc. | 1 | $255,000 |
| Yoh, A Day & Zimmermann Company | 1 | $116,002 |
| Lynxkite Inc. | 1 | $144,000 |
| Dash Bio, Inc. | 1 | $107,000 |
Tiotalan dreuchd
- Investigator I4
- Associate Director, Precision Medicine2
- Scientist2
- Manager Quantitative Clinical Pharmacology2
- mRNA - Bioassay Senior Scientist2
- Scientist I2
- Senior Scientist2
- Director, Translational Biology1
- Principal Engineer, Manufacturing Sciences and Technology1
- Associate Director, Pharmacovigilance Scientist & Operations1
- Sr. Research Associate1
- Investigation I1
- Principal Scientist1
- Senior Research Associate Scientist II, Formulation Research1
- mRNA - Scientist, Delivery and Formulation Development1
Luchd-taic H-1B ann an Waltham, MA →
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).